Bassam Abu Jawdeh, MD
Transplant Surgery · Scottsdale, AZNPI 1669683470
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $94,413 of the $115,651 with a category attached, or 81.6%. Every reported general payment came from a single manufacturer, AstraZeneca. Reporting peaked in 2019 at $76,596 and has fallen 99.3% since, to $530 in 2022. Among transplant surgery clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 141 payments — averaging $820.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$116K
What the payments were for
- Speaking & faculty fees$94,41382%
- Travel & lodging$17,50215%
- Food & beverage$3,7363%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 141 | $115,651 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$115,651 in reported general payments places this provider in the 95th percentile of 21 transplant surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valganciclovir Hcl | 82 | $18,054 |
| EliquisApixaban | 19 | $13,167 |
| LokelmaSodium Zirconium Cyclosilicate | 17 | $11,104 |
| Fluconazole | 148 | $5,260 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 91 | $559 |
| Prednisone | 76 | $315 |
| Pantoprazole Sodium | 29 | $269 |
| Famotidine | 28 | $262 |
| Carvedilol | 40 | $225 |
| Nifedipine ErNifedipine | 17 | $213 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $183 |
| Tamsulosin Hcl | 12 | $155 |
| Atorvastatin Calcium | 32 | $88 |
| Metoprolol Succinate | 11 | $67 |
| Metoprolol Tartrate | 15 | $37 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaLokelma | $115,651 | $11,10417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 21 transplant surgery providers in Arizona.
Other transplant surgery in Scottsdale
- Nitin KatariyaScottsdale$26K
- Amit MathurScottsdale$18K
- Jack HarbellScottsdale$8K
- Kayla MirieScottsdale$4K
- Brianna RuchScottsdale$4K
- Adyr MossScottsdale$3K
- Ingrid WoelfelScottsdale$3K
- Andrew SingerScottsdale$2K
- Winston HewittScottsdale$836
- Kunam ReddyScottsdale$156
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.